Press Release
This document provides integrated information to the media. In some instances, information on products or drug candidates under development may be included, but this is intended for members of the media, shareholders, and investors. The information is not intended for promotional or advertising purposes, or as medical advice, etc.
-
Research & DevelopmentJCR Pharmaceuticals to Present at the 18th International Symposium on MPS and Related Lysosomal Diseases 2026
-
OtherJCR Pharmaceuticals Receives “The Prize of the Minister of Education, Culture, Sports, Science, and Technology” at the 2026 National Commendation for Invention
-
Research & DevelopmentJCR Pharmaceuticals Presents Preclinical Gene Therapy Data that Demonstrate Promising Central Nervous System Uptake at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
-
Management & FinanceFY2025 Results Briefing Session - Script
-
Management & FinanceFY2025 Results Briefing Session - Movie
-
Management & FinanceFY2025 Results Briefing Session - Material
-
Management & FinanceFY2025 Full Year Financial Report
-
Management & FinanceNotice Concerning Partial Corrections to the Annual Securities Report for Past Fiscal Years and the Consolidated Financial Results for the Nine Months Ended December 31, 2025 (FY2025) and Other Relevant Documents
-
Research & DevelopmentJCR Pharmaceuticals to Present at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
-
Management & FinanceRevision of Consolidated Financial Forecasts for Fiscal Year Ended March 31, 2026